170 related articles for article (PubMed ID: 8972706)
21. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.
Sone S; Fidler IJ
J Immunol; 1980 Dec; 125(6):2454-60. PubMed ID: 7430635
[TBL] [Abstract][Full Text] [Related]
22. Priming effect of muramyl peptides for induction by lipopolysaccharide of tumor necrosis factor production in mice.
Parant M; Parant F; Vinit MA; Jupin C; Noso Y; Chedid L
J Leukoc Biol; 1990 Feb; 47(2):164-9. PubMed ID: 2303750
[TBL] [Abstract][Full Text] [Related]
23. Endocytic and tumoricidal heterogeneity of rat liver macrophage populations.
Daemen T; Veninga A; Roerdink FH; Scherphof GL
Sel Cancer Ther; 1989; 5(4):157-67. PubMed ID: 2623381
[TBL] [Abstract][Full Text] [Related]
24. MDP(Lysyl)GDP, a nontoxic muramyl dipeptide derivative, inhibits cytokine production by activated macrophages and protects mice from phorbol ester- and oxazolone-induced inflammation.
Zunic M; Bahr GM; Mudde GC; Meingassner JG; Lam C
J Invest Dermatol; 1998 Jul; 111(1):77-82. PubMed ID: 9665390
[TBL] [Abstract][Full Text] [Related]
25. Involvement of ERK, a MAP kinase, in the production of TGF-beta by macrophages treated with liposomes composed of phosphatidylserine.
Otsuka M; Tsuchiya S; Aramaki Y
Biochem Biophys Res Commun; 2004 Nov; 324(4):1400-5. PubMed ID: 15504369
[TBL] [Abstract][Full Text] [Related]
26. The effect of liver macrophages on in vitro cytolytic activity of 5FU and FUdR on colon carcinoma cells: evidence of macrophage activation.
Daemen T; Regts J; Morselt H; Scherphof GL
Int J Immunopharmacol; 1992 Jul; 14(5):857-64. PubMed ID: 1387390
[TBL] [Abstract][Full Text] [Related]
27. Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide.
Le Contel C; Temime N; Charron DJ; Parant MA
J Immunol; 1993 May; 150(10):4541-9. PubMed ID: 8482846
[TBL] [Abstract][Full Text] [Related]
28. Effect of free or liposome-encapsulated muramyl dipeptide on uptake and intracellular survival of Listeria monocytogenes in mouse peritoneal macrophages in vitro.
Bakker-Woudenberg IA; Lokerse AF; Vink-van den Berg JC; Roerdink FH
Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):603-9. PubMed ID: 2506020
[TBL] [Abstract][Full Text] [Related]
29. Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide.
Fidler IJ; Sone S; Fogler WE; Barnes ZL
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1680-4. PubMed ID: 6940181
[TBL] [Abstract][Full Text] [Related]
30. Comparative studies of cytotoxicity and the release of TNF-alpha, nitric oxide, and eicosanoids of liver macrophages treated with lipopolysaccharide and liposome-encapsulated MTP-PE.
Dieter P; Ambs P; Fitzke E; Hidaka H; Hoffmann R; Schwende H
J Immunol; 1995 Sep; 155(5):2595-604. PubMed ID: 7650390
[TBL] [Abstract][Full Text] [Related]
31. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators.
Fidler IJ; Barnes Z; Fogler WE; Kirsh R; Bugelski P; Poste G
Cancer Res; 1982 Feb; 42(2):496-501. PubMed ID: 7055801
[TBL] [Abstract][Full Text] [Related]
32. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.
Saiki I; Fidler IJ
J Immunol; 1985 Jul; 135(1):684-8. PubMed ID: 3923117
[TBL] [Abstract][Full Text] [Related]
33. Liposomal muramyl dipeptide therapy of experimental M5076 liver metastases in mice.
Phillips NC; Tsao MS
Cancer Immunol Immunother; 1991; 33(2):85-90. PubMed ID: 2036662
[TBL] [Abstract][Full Text] [Related]
34. Lack of production of interleukin 1 by human blood monocytes activated to the antitumor state by liposome-encapsulated muramyl tripeptide.
Tandon P; Utsugi T; Sone S
Cancer Res; 1986 Oct; 46(10):5039-44. PubMed ID: 3489519
[TBL] [Abstract][Full Text] [Related]
35. Modulation of murine macrophage nitric oxide synthesis by liposomal phospholipids: correlation with liposome immune adjuvant activity.
Phillips NC; Gagné L
J Drug Target; 1995; 3(2):137-47. PubMed ID: 7496727
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of negatively charged liposomes on nitric oxide production from macrophages stimulated by LPS.
Aramaki Y; Nitta F; Matsuno R; Morimura Y; Tsuchiya S
Biochem Biophys Res Commun; 1996 Mar; 220(1):1-6. PubMed ID: 8602825
[TBL] [Abstract][Full Text] [Related]
37. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
Phillips NC; Chedid L; Bernard JM; Level M; Lefrancier P
J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784
[TBL] [Abstract][Full Text] [Related]
38. Correction of defective tumoricidal activity of macrophages from A/J mice by liposomal immunomodulators.
Phillips NC; Skamene E; Chedid L
Immunopharmacology; 1988; 15(1):1-10. PubMed ID: 3360595
[TBL] [Abstract][Full Text] [Related]
39. Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases.
Fidler IJ; Schroit AJ
J Immunol; 1984 Jul; 133(1):515-8. PubMed ID: 6373933
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of Fc receptor expression in guinea pig peritoneal exudate macrophages by muramyl dipeptide or lipopolysaccharide.
Yagawa K; Kaku M; Ichinose Y; Nagao S; Tanaka A; Aida Y; Tomoda A
J Immunol; 1985 Jun; 134(6):3705-11. PubMed ID: 2985692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
